Pridopidine Reverses Phencyclidine-Induced Memory Impairment

Pridopidine is in clinical trials for Huntington's disease treatment. Originally developed as a dopamine D(2) receptor (D(2)R) ligand, pridopidine displays about 100-fold higher affinity for the sigma-1 receptor (sigma-1R). Interestingly, pridopidine slows disease progression and improves motor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahlholm, Kristoffer, Valle-León, Marta, Fernández-Dueñas, Víctor, Ciruela, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902730/
https://www.ncbi.nlm.nih.gov/pubmed/29692729
http://dx.doi.org/10.3389/fphar.2018.00338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902730/
https://www.ncbi.nlm.nih.gov/pubmed/29692729
http://dx.doi.org/10.3389/fphar.2018.00338

Ejemplares similares